Skip to the page

Data / Drug companies / Oxidation-Reduction Agent

Oxidation-Reduction Agent drugs: 2 drugs from 24 companies in the FDA NDC directory

Oxidation-Reduction Agent is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 37 products in this class from 24 companies, covering 2 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 5, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 24Companies
  • 37Products
  • 2Drugs by generic name

Drugs in the Oxidation-Reduction Agent class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Methylene blue2515
Urinary antiseptic antispasmodic11

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
American Regent, Inc.4injectionNew drug applications (NDA)April 8, 2020
Zydus Lifesciences Limited3injectionGeneric drugs (ANDA)April 1, 2026
Zydus Pharmaceuticals USA Inc.3injectionGeneric drugs (ANDA)April 1, 2026
Allegis Pharmaceuticals, LLC2capsuleOther unapproved drugsFebruary 25, 2025
Amneal Pharmaceuticals LLC2injection, solutionGeneric drugs (ANDA)March 3, 2025
Bpi Labs LLC2injectionOther unapproved drugsMay 15, 2023
Edwards Pharmaceuticals, Inc.2tablet, coatedOther unapproved drugsNovember 19, 2010
Method Pharmaceuticals, LLC2tablet; capsuleOther unapproved drugsDecember 1, 2015
Steriscience Specialties Private Limited2injection, solutionGeneric drugs (ANDA)January 7, 2026
Beijing Junge Technology Co., Ltd.1solutionOver the counter monograph drugsJanuary 10, 2025
Chengdu Shuode Pharmaceutical Co., Ltd1injectionGeneric drugs (ANDA)December 23, 2025
Cintex Services, LLC1tabletOther unapproved drugsOctober 5, 2026
Doral Pharmamedics Inc DBA A.G. Marin Pharmaceuticals1tabletOther unapproved drugsOctober 7, 2022
Fast Sold LLC1solutionOver the counter monograph drugsDecember 1, 2024
Glenmark Pharmaceuticals Inc., USA1injectionGeneric drugs (ANDA)December 23, 2025
Guna Spa1solution/ dropsUnapproved homeopathic productsMay 23, 2006
Hikma Pharmaceuticals USA Inc.1injection, solutionGeneric drugs (ANDA)June 5, 2025
Meitheal Pharmaceuticals Inc.1injectionGeneric drugs (ANDA)January 23, 2025
Mission Pharmacal Company1tablet, coatedOther unapproved drugsNovember 7, 2023
Nexus Pharmaceuticals LLC1injection, solutionGeneric drugs (ANDA)February 1, 2025
Nucleic Products, LLC1liquidUnapproved homeopathic productsMay 3, 2021
Olic (Thailand) Limited1injection, solutionGeneric drugs (ANDA)February 1, 2025
Viatris Specialty LLC1tabletOther unapproved drugsJanuary 12, 2015
Xiromed, LLC1injectionGeneric drugs (ANDA)September 28, 2025

Dosage forms

Dosage formProductsShare
Injection1643.2%
Injection, solution718.9%
Tablet410.8%
Capsule38.1%
Tablet, coated38.1%
Solution25.4%
Solution/ drops12.7%
Liquid12.7%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.